Loading…
Canton Strategic Holdings, Inc. is projected to decline to $2.14 by 2027, a -10% move from its current price of $2.38. CNTN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.26 | $2.38 | $2.52 | +0.11% |
| Jul 14 | $2.21 | $2.39 | $2.58 | +0.23% |
| Jul 15 | $2.17 | $2.39 | $2.62 | +0.34% |
| Jul 16 | $2.14 | $2.39 | $2.67 | +0.46% |
| Jul 17 | $2.12 | $2.39 | $2.70 | +0.57% |
| Jul 18 | $2.10 | $2.40 | $2.74 | +0.69% |
| Jul 19 | $2.08 | $2.40 | $2.77 | +0.80% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.08 | $2.40 | $2.77 | +0.80% |
| Week 2 | $1.97 | $2.42 | $2.97 | +1.61% |
| Week 3 | $1.90 | $2.44 | $3.13 | +2.42% |
| Week 4 | $1.84 | $2.46 | $3.28 | +3.24% |
| Week 5 | $1.79 | $2.48 | $3.42 | +4.07% |
| Week 6 | $1.75 | $2.50 | $3.56 | +4.90% |
| Week 7 | $1.72 | $2.52 | $3.69 | +5.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Canton Strategic Holdings, Inc. operates in the healthcare sector and focuses on institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology, with activities that include validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management.
The company also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. It was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc.
in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.
CNTN is the asset Canton Strategic Holdings, Inc., a healthcare company with a current price of $2.32 and a market cap of $178.92M. It ranks 3886 by market capitalization among listed assets. The price is trading below the near-term averages, with the SMA50 listed at $3.04 and the SMA200 at $3.28, suggesting near-term weakness relative to longer-term trends.
The stock shows a 30-day trading range from $1.59 to $3.38, with near-term support at $2.30 and resistance at $3.54. The current technical posture is bearish, while the longer-run forecast depicts mixed to bullish potential, with several years showing meaningful upside and others showing moderation. The multi-year forecast presents a spectrum of outcomes, from flat to substantial gains, culminating in notable upside by 2050.
A major floor 37.5% below — a decisive break under it would weaken the trend.
The nearest floor, 3.8% below — buyers have tended to step in here.
The nearest ceiling, 48.7% above — a clean break opens room to run.
A major ceiling 96.6% above — clearing it would confirm fresh momentum.
Key CNTN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNTN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.41 | Sell | $2.44 | Sell |
| MA 10 | $2.64 | Sell | $2.58 | Sell |
| MA 20 | $2.89 | Sell | $2.74 | Sell |
| MA 50 | $3.00 | Sell | $2.98 | Sell |
| MA 100 | $3.44 | Sell | $3.16 | Sell |
| MA 200 | $3.27 | Sell | $3.36 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.45 | Neutral |
| Stoch RSI (14) | 16.27 | Buy |
| CCI (20) | -112.00 | Sell |
| Williams %R (14) | -90.43 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -26.32 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 9.57 | Buy |
| TRIX (15) | -0.50 | Sell |
| Awesome (5,34) | -0.47 | Sell |
| Ultimate (7,14,28) | 27.71 | Buy |
| Momentum (10) | -0.30 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 2.22 | Buy |
| ADX (14) | 16.05 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is bearsih overall, with RSI14 at 40 indicating room to fall before oversold conditions. The price is trading below the 50-day and 200-day moving averages, with SMA50 at $3.04 and SMA200 at $3.28, which reinforces the near-term downward bias. The 30-day trading range stretches from $1.59 to $3.38, while the stock currently sits near the $2.30 support level and faces resistance at $3.54.
Annualized volatility stands at 100%, underscoring the sizable near-term swings possible.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.29 | $2.38 | $3.39 | 0% | Neutral | |
| $1.55 | $2.14 | $3.19 | -10% | Neutral | |
| $1.73 | $2.53 | $4.02 | +6% | Neutral | |
| $2.34 | $3.61 | $6.01 | +52% | Bullish | |
| $2.00 | $3.24 | $5.63 | +36% | Bullish | |
| $1.84 | $3.11 | $5.58 | +31% | Bullish | |
| $1.87 | $3.30 | $6.11 | +38% | Bullish | |
| $1.48 | $2.71 | $5.17 | +14% | Neutral | |
| $1.53 | $2.93 | $5.72 | +23% | Bullish | |
| $1.76 | $3.50 | $7.00 | +47% | Bullish | |
| $1.84 | $4.08 | $8.96 | +71% | Bullish | |
| $4.17 | $9.26 | $21.30 | +289% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.29 | $2.38 | $3.01 | +0.00% |
| August 2026 | $2.20 | $2.67 | $3.37 | +12.00% |
| September 2026 | $2.15 | $2.64 | $3.40 | -0.94% |
| October 2026 | $2.00 | $2.49 | $3.27 | -5.57% |
| November 2026 | $2.01 | $2.53 | $3.36 | +1.38% |
| December 2026 | $1.98 | $2.52 | $3.39 | -0.36% |
Click any year to see its month-by-month CNTN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CNTN could reach as high as $3.39, with a base case around $2.38 and support toward $2.29 — roughly 0% from $2.38. Price action looks broadly range-bound.
Expect CNTN to range from $1.55 to $3.19 through 2027. The $2.14 average target implies a -10% move from current prices. That is -10% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The CNTN price prediction for 2028 points to an average of $2.53 (low $1.73, high $4.02) — a potential gain of +6% on today's $2.38. Price action looks broadly range-bound.
In 2029, CNTN is projected to trade between $2.34 and $6.01, averaging $3.61 — a potential gain of +52% from today's $2.38. That is up +42% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Canton Strategic Holdings, Inc.'s 2030 outlook centres on $3.24, within a $2.00 to $5.63 range. That is -10% versus the projected 2029 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2031, CNTN could reach as high as $5.58, with a base case around $3.11 and support toward $1.84 — roughly +31% from $2.38. Buyers look set to stay in control over this stretch.
Expect CNTN to range from $1.87 to $6.11 through 2032. The $3.30 average target implies a +38% move from current prices. That is up +6% on the projected 2031 average. Momentum favours further upside here.
The CNTN price prediction for 2033 points to an average of $2.71 (low $1.48, high $5.17) — a potential gain of +14% on today's $2.38. A consolidation phase looks the most probable path here.
In 2034, CNTN is projected to trade between $1.53 and $5.72, averaging $2.93 — a potential gain of +23% from today's $2.38. That is up +8% on the projected 2033 average. Momentum favours further upside here.
Canton Strategic Holdings, Inc.'s 2035 outlook centres on $3.50, within a $1.76 to $7.00 range. That is up +19% on the projected 2034 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CNTN could reach as high as $8.96, with a base case around $4.08 and support toward $1.84 — roughly +71% from $2.38. Momentum favours further upside here.
Expect CNTN to range from $4.17 to $21.30 through 2050. The $9.26 average target implies a +289% move from current prices. That is up +127% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CNTN today (≈ 420.168067 CNTN) could be worth
$3,890.3
+$2,890.3 (+289%) by 2050 · US Dollar
Based on the average projected CNTN price of $9.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNTNwould be worth at today's price.
$1,000 invested in CNTN on Jul 10, 2025 (≈ 564.971758 CNTN) would be worth
$1,344.63
+$344.63 (+34.5%) today · 1.34× · US Dollar
Based on a CNTN entry price of $1.77 vs. today's $2.38.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.84 | $838.03 | -16.2% |
| 1 month ago | $2.95 | $806.78 | -19.3% |
| 3 months ago | $2.98 | $797.32 | -20.3% |
| 6 months ago | $3.01 | $790.7 | -20.9% |
| 1 year ago | $1.77 | $1,344.63 | +34.5% |
| All time (4.5y) ago | $1,305 | $1.82 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNTN forecast.
Our base-case forecast reaches $4.80 around 2050.
Implied market cap at $4.80: $370.19M
The multi-year forecast shows a path of rising averages and growing upside, with the 2029 average price at $3.55 and a bullish sentiment, rising further to an average of $4.01 by 2040 and $9.09 by 2050, accompanied by ROI estimates of 53.2% in 2029, 36.8% in 2030, 31.6% in 2031, 39.3% in 2032, 23.4% in 2034, 47.9% in 2035, 72.8% in 2040, and 292% by 2050. These numbers imply meaningful long-term upside potential from the current level of $2.32, though early years show some flat or negative momentum (e.g., 2027 with -10.8% ROI and 2023-like ranges). The max forecast by 2050 is $20.92, illustrating substantial longer-term upside under the provided assumptions.
These are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
Avg $3.17, with a min of $1.96 and a max of $5.51, and an ROI of 36.8%; sentiment is BULLISH.
Near-term uncertainty persists with a neutral to bearish bias, but the long-run forecast shows significant upside, including a 53.2% ROI in 2029 and up to 292% by 2050.
Yes, the forecast lists a 2050 max of $20.92, indicating potential long-term upside within the stated estimates (not a guarantee).
$1.59 to $3.38.
Current price is $2.32 and market cap is $178.92M.
Canton Strategic Holdings, Inc. Community Discussion
0Share your Canton Strategic Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.